No Data
No Data
Micro-Tech (688029.SH): Chairman Long Xiaohui proposes to repurchase shares for 20-40 million yuan.
On July 8th, Gelunhui reported that Micro-Tech (688029.SH) proposed to repurchase some social public shares of the company through centralized bidding trading, based on the company's operation and financial condition and other factors, and in accordance with relevant laws and regulations, initiated by Chairman Long Xiaohui. The total amount of repurchase funds in this transaction is no less than RMB 20 million (inclusive) and no more than RMB 40 million (inclusive).
Here's What's Concerning About Micro-Tech (Nanjing)Ltd's (SHSE:688029) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and al
Micro-tech (688029.SH) will distribute RMB 10 yuan for every 10 shares in 2023, with the share registration day on June 21.
Nanwei Medical (688029.SH) announced that it will distribute an annual equity dividend in 2023, with a cash dividend of 10 yuan (including tax) for every 10 shares. The record date for shareholders is June 21.
Is Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Recent Stock Performance Tethered To Its Strong Fundamentals?
Micro-Tech (Nanjing)Ltd's (SHSE:688029) stock is up by a considerable 14% over the past month. Given the company's impressive performance, we decided to study its financial indicators more closely a
Nanwei Medical (688029.SH): Appoints Li Changqing as the company's executive president
Gelonghui, May 20 | Nanwei Medical (688029.SH) announced that the board of directors agreed to appoint Mr. CHANGQING LI (Li Changqing) as the company's executive president. His role is to assist the president to preside over the overall production and operation management of the company in accordance with the president's authorization. The term of office starts from the date of review and approval by the board of directors and ends on the date the term of the third board of directors expires.
Huakang Limited, the major shareholder of Nanwei Medical (688029.SH), reduced its holdings by 1.04%
Southern Weimedicine (688029.SH) Notice, May 15, 2024 to May 17, 2024, Public...
No Data